AOD-9604 acts upon fat metabolism
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
Symptoms of histamine intolerance vary from person to person, but some common symptoms associated with low DAO levels include: Skin symptoms: itching, hives, redness, eczema, or flushing Gastrointestinal symptoms: bloating, abdominal pain, diarrhea, gas, or nausea Respiratory symptoms: nasal congestion, sneezing, runny nose, or difficulty breathing Cardiovascular symptoms: irregular heartbeat, palpitations, or low blood pressure Neurological symptoms: headaches, migraines, dizziness, or fatigue Psychological symptoms: anxiety, irritability, or insomnia It's important to note that these symptoms can be caused by various factors and not just histamine intolerance or low DAO levels
PMID: 126 JainAPariharDKTiwaryBKushwahaM
